Tigermed Repurchases 3.41 Million A-Shares for RMB 133.44 Million, Lifts Treasury Stock to 23.67 Million

Bulletin Express
06/16

Hangzhou Tigermed Consulting Co., Ltd. (Tigermed) disclosed a share buyback executed on 16 June 2026 on the Shenzhen Stock Exchange. The company repurchased 3.41 million A-shares at prices ranging from RMB 38.66 to RMB 39.78 per share, investing a total of RMB 133.44 million. The volume-weighted average repurchase price was approximately RMB 39.12 per share.

Prior to the transaction, Tigermed had 717.65 million issued shares (excluding treasury shares) and 20.26 million treasury shares. Following the buyback, outstanding shares decreased by 0.35 % to 714.23 million, while treasury shares rose to 23.67 million. The total issued share capital remains unchanged at 737.90 million shares.

All repurchased shares are being held as treasury shares; no immediate cancellation plans were disclosed. The company confirmed that the operation complied with the rules of the Shenzhen Stock Exchange and the Hong Kong Stock Exchange’s Main Board requirements.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10